Obagi Skintrinsiq Clarifiying Protocol
salicylic acid, titanium dioxide, and zinc oxide · KIT · Obagi Cosmeceuticals LLC
Obagi Skintrinsiq Clarifiying Protocol is a kit containing salicylic acid, titanium dioxide, and zinc oxide. Manufactured by Obagi Cosmeceuticals LLC.
Key Facts
- Brand Name
- Obagi Skintrinsiq Clarifiying Protocol
- Generic Name
- salicylic acid, titanium dioxide, and zinc oxide
- NDC Code (Product)
62032-909- Manufacturer
- Obagi Cosmeceuticals LLC
- Dosage Form
- KIT
- Marketing Status
- Application #
- M020
- Marketing Start
- 08/01/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Obagi Skintrinsiq Clarifiying Protocol used for?
Obagi Skintrinsiq Clarifiying Protocol contains salicylic acid, titanium dioxide, and zinc oxide. It is a kit taken as directed. Consult your doctor for specific uses.
Is Obagi Skintrinsiq Clarifiying Protocol a controlled substance?
Obagi Skintrinsiq Clarifiying Protocol is not classified as a controlled substance by the DEA.
What is the generic name for Obagi Skintrinsiq Clarifiying Protocol?
The generic name for Obagi Skintrinsiq Clarifiying Protocol is salicylic acid, titanium dioxide, and zinc oxide. There are no other listed brand versions of salicylic acid, titanium dioxide, and zinc oxide.
What is the NDC code for Obagi Skintrinsiq Clarifiying Protocol ?
The NDC (National Drug Code) for Obagi Skintrinsiq Clarifiying Protocol is 62032-909, listed by Obagi Cosmeceuticals LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)